NCT04852796View on ClinicalTrials.gov

Efficacy and Safety of the Anti- COVID-19 Vaccin in Clinical Hematology Patients

CompletedOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

April 1, 2022

Study Completion Date

April 1, 2023

Conditions
Covid19Hematologic MalignancyVaccine Response Impaired
Interventions
OTHER

Patients with hemopathy

optimal humoral response at 1 month after COVID-19 vaccination

Trial Locations (1)

29000

Centre Hospitalier de Quimper Cornouaille, Quimper

All Listed Sponsors
lead

Centre Hospitalier de Cornouaille

OTHER

NCT04852796 - Efficacy and Safety of the Anti- COVID-19 Vaccin in Clinical Hematology Patients | Biotech Hunter | Biotech Hunter